These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17505298)

  • 41. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Lee MY; Ko KS; Song JH; Peck KR
    J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The current state of multidrug-resistant gram-negative bacilli in North America.
    Nicasio AM; Kuti JL; Nicolau DP
    Pharmacotherapy; 2008 Feb; 28(2):235-49. PubMed ID: 18225969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of old antibiotics in multidrug resistant bacterial infections.
    Maviglia R; Nestorini R; Pennisi M
    Curr Drug Targets; 2009 Sep; 10(9):895-905. PubMed ID: 19799544
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
    Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
    Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Aminoglycosides and polymyxins].
    Molina J; Cordero E; Palomino J; Pachón J
    Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):178-88. PubMed ID: 19303668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibiotics and endotoxic shock.
    McCabe WR
    Bull N Y Acad Med; 1975 Oct; 51(9):1084-95. PubMed ID: 1058731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units.
    Mastoraki A; Douka E; Kriaras I; Stravopodis G; Saroglou G; Geroulanos S
    Eur J Cardiothorac Surg; 2008 Jun; 33(6):1086-90. PubMed ID: 18339553
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
    Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA
    Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
    Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
    Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictive model of antimicrobial-resistant gram-negative bacteremia at the ED.
    Chiang WC; Chen SY; Chien KL; Wu GH; Yen AM; Su CP; Lee CC; Chen YC; Chang SC; Chen SC; Chen WJ; Chen TH
    Am J Emerg Med; 2007 Jul; 25(6):597-607. PubMed ID: 17606081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nosocomial infections in a medical-surgical intensive care unit.
    Aly NY; Al-Mousa HH; Al Asar el SM
    Med Princ Pract; 2008; 17(5):373-7. PubMed ID: 18685276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit.
    Shorr AF
    Crit Care Med; 2009 Apr; 37(4):1463-9. PubMed ID: 19242341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Levofloxacin in the treatment of nosocomial infection in critically ill patients].
    Alvarez Lerma F; Romero Luján JL; Morón Jiménez A; Ortiz López R; Borges Sá M; Grau Cerrato S; Gracia Arnillas MP;
    Rev Esp Quimioter; 2008 Jun; 21(2):83-92. PubMed ID: 18509767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Colistin susceptibility testing by Etest and disk diffusion methods.
    Galani I; Kontopidou F; Souli M; Rekatsina PD; Koratzanis E; Deliolanis J; Giamarellou H
    Int J Antimicrob Agents; 2008 May; 31(5):434-9. PubMed ID: 18328674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Meticillin-resistant Staphylococcus aureus control in an intensive care unit: a 10 year analysis.
    Raineri E; Crema L; De Silvestri A; Acquarolo A; Albertario F; Carnevale G; Latronico N; Petrosillo N; Tinelli C; Zoncada A; Pan A
    J Hosp Infect; 2007 Dec; 67(4):308-15. PubMed ID: 17945395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Universal Culture Medium for Screening Polymyxin-Resistant Gram-Negative Isolates.
    Nordmann P; Jayol A; Poirel L
    J Clin Microbiol; 2016 May; 54(5):1395-9. PubMed ID: 26984971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative in vitro activity of polymyxins against carbapenem susceptible and resistant non-fermenters from critically ill-patients.
    Gupta V; Bansal N; Palta S; Gombar S; Chander J
    Indian J Med Microbiol; 2014; 32(2):203-4. PubMed ID: 24713920
    [No Abstract]   [Full Text] [Related]  

  • 60. Polymyxins revisited.
    Landman D; Georgescu C; Martin DA; Quale J
    Clin Microbiol Rev; 2008 Jul; 21(3):449-65. PubMed ID: 18625681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.